<DOC>
	<DOC>NCT00668967</DOC>
	<brief_summary>The purpose of this study is to demonstrate bioequivalence of single doses of two verapamil formulations</brief_summary>
	<brief_title>Bioequivalence Study Of Verapamil</brief_title>
	<detailed_description />
	<mesh_term>Verapamil</mesh_term>
	<criteria>Healthy male and/or female subjects Mass Index (BMI) of approximately 18 to 30 kg/m2 Any condition possibly affecting drug absorption A positive urine drug screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Cardiovascular Diseases</keyword>
	<keyword>Hypertension</keyword>
</DOC>